Page last updated: 2024-11-08

n-methylglutamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-L-glutamic acid : A N-methyl-L-alpha-amino acid with L-glutamic acid as the amino acid component. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

methyl-L-glutamic acid : A non-proteinogenic L-alpha-amino acid that is L-glutamic acid substituted with a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439377
CHEBI ID16440
SCHEMBL ID162038
MeSH IDM0452986

Synonyms (35)

Synonym
CHEBI:16440
n-methylglutamic acid
(2s)-2-(methylamino)pentanedioic acid
n-methyl-l-glutamic acid
n-methyl-l-glutamate
C01046 ,
n-methylglutamate
F64E24AA-8209-446F-8734-94A27A9011B3
6753-62-4
AKOS006272673
128724-80-1
557zpu13hk ,
l-glutamic acid, n-methyl-
nsc 109187
glutamic acid, n-methyl-, l-
methyl glutamic acid
unii-557zpu13hk
methyl glutamic acid [inci]
SCHEMBL162038
XLBVNMSMFQMKEY-BYPYZUCNSA-N
(s)-2-(methylamino)pentanedioic acid
n-methyl-d-glutamate
n-alpha-methyl-l-glutamic acid (me-l-glu-oh)
mfcd00065920
n-methyl-l-glutamicacid
(2s)-2-(methylamino)pentanedioate
CS-0208028
Q15298280
AM9408
n-mathyl-l-glutamic acid
methyl-l-glutamic acid
F15110
BS-24762
(s)-2-(methylamino)pentanedioicacid
DTXSID101035891
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
N-methyl-L-alpha-amino acidAn non-proteinogenic L-alpha-amino acid in which the amino group bears one or more methyl groups.
methyl-L-glutamic acidA non-proteinogenic L-alpha-amino acid that is L-glutamic acid substituted with a methyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's7 (58.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.49 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]